Clinical Trials Directory

Trials / Completed

CompletedNCT06298903

Impact of Hip Activation Compared to Hip Plus Balance Training on the Forward-Step-Down Test

The Effect of a Hip Activation Home Exercise Program (HEP) Compared to a Hip Activation + Single Leg Balance HEP on the Forward Step-Down Test in Healthy Females

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Louisiana State University Health Sciences Center Shreveport · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to determine the impact of a hip activation home exercise program (HEP) compared to a hip activation + single leg balance HEP on performance of the Forward-Step-Down Test (FSDT) in healthy females. Participants will be assigned to the control (hip activation HEP only) or experimental (hip activation + single leg balance HEP). Following the pre-test data collection, participants will complete their HEP for 8 weeks. They will return to the lab for post-test measurements.

Conditions

Interventions

TypeNameDescription
OTHERHip ActivationSidelying hip abduction, side plank with hip abduction, clamshell (hip abduction + external rotation), side plan with clamshell, and quadruped fire hydrant exercises will be performed for 1 minute isometric holds, 2 times per week for 8 weeks.
OTHERHip activation + Single leg balanceHip activation HEP: Sidelying hip abduction, side plank with hip abduction, clamshell (hip abduction + external rotation), side plan with clamshell, and quadruped fire hydrant exercises will be performed for 1 minute isometric holds, 2 times per week for 8 weeks. Single leg balance: variety of single leg balance exercises with different upper extremity and lower extremity positions to provide different balance stimuli. Weeks are alternated performing these exercises with eyes open and eyes closed.

Timeline

Start date
2024-01-12
Primary completion
2024-03-25
Completion
2024-08-01
First posted
2024-03-07
Last updated
2024-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06298903. Inclusion in this directory is not an endorsement.